Microtek International Inc. and Microtek Research and Development Ltd. develop, manufacture and market advanced health products and services to the world's fastest-growing agriculture sector, aquaculture since 1983.
In particular, Microtek serves the aquaculture industry across Canada, the U.S.A., Chile, Scotland and other European countries. Microtek uses proprietary and patented technologies to deliver market-leading aquatic vaccines and diagnostics, and is developing innovative oral and viral vaccines.
The company is experienced in all aspects of Microbiology and Biochemistry, including: development of vaccines and diagnostics; alternative methods of drug delivery; and monoclonal and polyclonal antibody production.
Microtek also offers fish health services with diagnostic techniques including ELISA, immunofluorescence assays, tissue culture, and genetic techniques.
Microtek maintains an extensive research network including an alliance with the University of Victoria, University of British Columbia, National Research Council (Institute for Marine Biosciences), Oregon State University, Mississippi State University, Massachusetts Institute of Technology and the University of Berne (Switzerland).